Cargando…
Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion
BACKGROUND: Percutaneous left atrial appendage occlusion (LAAO) provides an alternative for poor candidates for long-term oral anticoagulation (OAC). To prevent device-related thrombosis (DRT), OAC should be continued for the first 45 days to allow complete endothelialization post-LAAO implantation....
Autores principales: | Ge, Heng, Zhang, Chi, Qiao, Zhi-Qing, Hao, Zi-Yong, Li, Zheng, Gu, Zhi-Chun, Jiang, Li-Sheng, He, Ben, Pu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450492/ https://www.ncbi.nlm.nih.gov/pubmed/35849447 http://dx.doi.org/10.1177/00368504221113194 |
Ejemplares similares
-
Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients
por: Zhai, Zhengqin, et al.
Publicado: (2019) -
Left Atrial Appendage Closure – The WATCHMAN Device
por: Akinapelli, Abhilash, et al.
Publicado: (2015) -
Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement
por: Ahuja, Tania, et al.
Publicado: (2019) -
Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban
por: Miwa, Yosuke, et al.
Publicado: (2016) -
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
por: Reddy, Vivek Y., et al.
Publicado: (2016)